HEMODYNAMIC-EFFECTS OF COMBINED TREATMENT WITH SOMATOSTATIN ANALOG (SMS-201-995) AND LOW-DOSE ISOSORBIDE DINITRATE ON PORTAL-HYPERTENSION IN CONSCIOUS CIRRHOTIC RATS

被引:12
作者
HORI, N [1 ]
OKANOUE, T [1 ]
SAWA, Y [1 ]
ITOH, Y [1 ]
MORI, T [1 ]
TAKAMI, S [1 ]
KASHIMA, K [1 ]
机构
[1] KYOTO PREFECTURAL UNIV MED,DEPT INTERNAL MED 3,KAWARAMACHI HIROKOJI KAMIGYO KU,KYOTO 602,JAPAN
关键词
SOMATOSTATIN ANALOG (SMS-201-995); ISOSORBIDE DINITRATE; COMBINATION THERAPY; PORTAL HYPERTENSION; RADIOACTIVE MICROSPHERE METHOD;
D O I
10.1007/BF02361244
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The authors investigated whether combined treatment with the somatostatin analogue, SMS 201-995, and low-dose isosorbide dinitrate enhanced the hemodynamic effects of the individual agents on rats with thioacetamide-induced cirrhosis. Four groups of cirrhotic rats received SMS 201-995 (0.1 mug.min-1.kg-1), isosorbide dinitrate (10 mug.min-1.kg-1), both agents, or placebo, respectively. Hemodynamics were measured serially in conscious rats, using a radioactive microsphere method. SMS 201-995 reduced portal venous inflow 21 +/- 4% and portal pressure 17 +/- 3%. Isosorbide dinitrate decreased portal venous inflow 20 +/- 4%, by inducing splanchnic vasoconstriction mediated by low pressure baroreflexes, and this agent also decreased portal pressure, by 14 +/- 2%. Portal venous resistance rose 7.6 +/- 3% with isosorbide dinitrate alone, but decreased 18 +/- 4% with combination therapy. This effect may have been induced by the pronounced vasodilatory effect of isosorbide dinitrate on the venous vasculature, since the reflex splanchnic vasoconstriction that occurs with low-dose isosorbide dinitrate disappears when this agent is combined with SMS 201-995. The decrease in portal pressure was more marked (22 +/- 4%) and changes in systemic hemodynamics were milder with the combined treatment. It was concluded that combination therapy with SMS 201-995 and low-dose isosorbide dinitrate may be beneficial for portal hypertension in liver cirrhosis.
引用
收藏
页码:460 / 468
页数:9
相关论文
共 37 条
[1]  
Groszmann R.J., Kravetz J., Bosch J., Et al., Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension, Hepatology, 2, pp. 757-762, (1982)
[2]  
Mols P., Hallemans R., Kuyk M.V., Et al., Hemodynamic effects of vasopressin, alone and in combination with nitroprusside, in patients with liver cirrhosis and portal hypertension, Ann Surg, 199, pp. 176-181, (1984)
[3]  
Tsai Y.T., Lay C.S., Lai K.H., Et al., Controlled trials of vasopressin plus nitroglycerin vs vasopressin alone in the treatment of bleeding esophageal varices, Hepatology, 6, pp. 406-409, (1986)
[4]  
Gion A.E., Westaby D., Hegarty J., Et al., A randomized trial of vasopressin and vasopressin plus nitroglycerin in the control of acute variceal hemorrhage, Hepatology, 6, pp. 410-413, (1986)
[5]  
Westaby D., Gion A., Hayes P.C., Et al., Haemodynamic response to intravenous vasopressin and nitroglycerin in portal hypertension, Gut, 29, pp. 372-377, (1988)
[6]  
Bosch J., Groszmann R.J., Garcia-Pagan J.C., Et al., Association of transdermal nitroglycerin and vasopressin infusion in the treatment of variceal hemorrhage: A placebo-controlled clinical trial, Hepatology, 10, pp. 962-968, (1989)
[7]  
Bosch J., Kravetz D., Rodes J., Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: Comparison with vasopressin, Gastroenterology, 80, pp. 518-525, (1981)
[8]  
Morgan J.S., Groszmann R.I., Somatostatin in portal hypertension, Digestive Diseases and Sciences, 34, pp. 40-47, (1989)
[9]  
Wahren J., Eriksson L.S., The influence of a long-acting somatostatin analogue on splanchnic hemodynamics and metabolism in healthy subjects and patients with liver cirrhosis, Scand J Gastroenterol, 21, pp. 103-108, (1986)
[10]  
Eriksson L.S., Brundin T., Soderlung C., Et al., Haemodynamic effects of a long-acting somatostatin analogue in patients with liver cirrhosis, Scand J Gastroenterol, 2, pp. 919-925, (1987)